REVELATION BIOSCIENCES, INC.

Our business is subject to various risks, including those described below and in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.

If Revelation is not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our common stock and public warrants.

Revelation’s common stock and Public Warrants are listed on the Nasdaq Capital Market listing tier (“Nasdaq Capital Market”) under the symbols “REVB” and “REVBW,” respectively. If Nasdaq delists the Revelation common stock and Public Warrants from trading on its exchange for failure to meet the listing standards such as the minimum public stockholders equity requirement, minimum bid price, minimum market value of publicly-held shares, for failure to hold an annual stockholders meeting, or any other listing standards, we and our stockholders could face significant material adverse consequences including:

•

•

reduced liquidity for Revelation’s securities;

•

a determination that the Revelation common stock is a “penny stock” which will require brokers trading in the Revelation common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for Revelation’s securities;

•

•

Nasdaq has proposed, but the SEC has not yet approved, a rule that would require automatic delisting if the market value of a company's listed securities remains below $5 million for 30 consecutive business days. The proposal would eliminate any cure period, preclude any automatic stay of suspension pending an appeal, and result in an immediate trading suspension upon Nasdaq's determination of non-compliance. The SEC has instituted formal proceedings to determine whether to approve or disapprove the proposed rule change, which remains pending as of the date of this filing. If adopted in its current form, this rule could materially increase the risk that our common stock is delisted, which would substantially reduce liquidity and market value.

a)

None.

b)

None.

c)

None.

Not applicable.

Not applicable.